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Abstract 
Background: Although the use of biomarkers to assess health outcomes has recently gained momentum, literature 
is still scarce for low- to middle-income countries. This paper explores the relationship between primary care coverage 
and individual health in Brazil using a dataset of blood-based biomarkers collected by the Brazilian National Health 
Survey. Both survey data and laboratory results were crossed with coverage data from the Family Health Strategy 
(ESF) program, the most important primary care program in Brazil; the coverage measures aim to capture both direct 
(household) and indirect (spill-over) effects.
Methods: The empirical strategy used a probit model to estimate the relationship between ESF program coverage 
and the likelihood of abnormal biomarker levels while controlling for a rich set of individual and household character-
istics based on data from the national survey.
Results: Household ESF coverage was associated with a lower likelihood of abnormal results for biomarkers related 
to anemia (marginal effect between − 2.16 and − 2.18 percentage points), kidney failure (between − 1.01 and − 1.19 
p.p.), and arterial hypertension (between − 1.48 and − 1.64 p.p). The likelihood of abnormal levels of white blood cells 
and thrombocytes was negatively related to primary care coverage (marginal effect between − 1.8 and − 2 p.p.). The 
spillover effects were relevant for kidney failure and arterial hypertension, depending on the regional level. Although 
not sensitive to household coverage, diabetes mellitus was negatively associated with the state supply of primary 
care, and abnormal cholesterol levels did not present any relationship with ESF program coverage.
Conclusions: The presence of spillover effects of ESF program coverage regarding these conditions reveals that the 
strengthening of primary care by increasing the household registration and the regional density of ESF teams is an 
efficient strategy to address important comorbidities.
Keywords: Primary care, Biomarkers, Probit, Impact evaluation, Universal health care, Low- to middle-income 
countries
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Background
The Family Health Strategy (ESF) program is the larg-
est primary health care program in Brazil. Launched in 
1993, the ESF program has, over the past two decades, 
spread gradually across Brazilian municipalities as part of 
a strategy to strengthen basic health care attention. The 
program is structured by health teams comprising one 
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physician, one nurse, one auxiliary nurse, and four to six 
community health agents. Community health workers 
are responsible for periodic home visits to local residents 
to assess their general health conditions and, if necessary, 
to give them referrals to outpatient clinics, where the rest 
of the team members are based.
Most of the existing literature on the topic assesses 
the impact of the ESF program [1], finding evidence 
that it has succeeded in reducing infant and/or mater-
nal mortality [2–7], the mortality rates of some diseases 
and comorbidities [8–11], and admission to outpa-
tient clinics and hospitals due to primary care-sensitive 
conditions [12–15]. However, a gap has been found in 
this literature, as the channels whereby the ESF pro-
gram’s actions affect individual health have not received 
deserved attention.
Up to 2008, every 5 years, the Brazilian Institute for 
Geography and Statistics (IBGE) included a special sup-
plement on health in its Annual National Household 
Sample Survey (PNAD) with specific questions regarding 
the health of the population. From 2013 onward, this spe-
cial supplement on health was converted into a broader 
separate survey called the National Health Survey (PNS). 
It contained more than 700 questions grouped into 21 
themes, including children’s health, women’s and elderly 
people’s health, chronic diseases, oral health, eating hab-
its, smoking habits, physical activity, health insurance 
coverage, search for medical services, hospital or out-
patient clinics, household income, visits by community 
agents (including ESF program), and self-assessment of 
health, among other themes [16].1
The PNS 2013 collected anthropometric meas-
ures (weight, height, and waist circumference) from 
household representatives and measured their blood 
pressure. A subsample of surveyed household repre-
sentatives was assigned to attend a laboratory clinic 
to collect biological material (blood and urine) to be 
tested for some biomarkers. In total, 8952 adult indi-
viduals over the age of 18 years had their biological 
material collected. The following laboratory tests were 
performed [18]: a hemogram and its components (red 
blood cell, white blood cell and platelet counts); gly-
cated hemoglobin and estimated average blood glu-
cose levels; total cholesterol levels and fractions (HDL 
and LDL); serial creatinine levels (from which the glo-
merular filtration rate was calculated [19]); and a serol-
ogy test for dengue (IgG). The excretion of creatinine, 
potassium, salt, and sodium was estimated in the urine 
samples [18]. The data of individual tests were made 
publicly available on the Oswaldo Cruz Foundation’s 
PNS website [20].2 The information on biomarkers in 
this dataset3 represents a unique opportunity to con-
tribute to the understanding of the individual channels 
of the ESF program’s impact on the prevalence of some 
diseases.
Most of the studies with biomarkers and health inter-
ventions focus on high-income countries and cover 
a wide range of purposes and methods [23–32]. This 
study aimed to contribute to a better understanding 
of the channels by which the ESF program affects indi-
vidual health in Brazil using the results of the laboratory 
tests described above. The main goal was to investi-
gate whether there is any relationship between primary 
health care and the biomarkers of the examined individu-
als. To the best of our knowledge, this is the first study 
that adopts this strategy to try to unveil the mechanisms 
through which primary care coverage may impact health 
in Brazil.
Methods
The set of diseases and comorbidities assessed in this 
study was limited by the blood-based biomarkers and 
the exams contained in the laboratory tests, focusing on 
conditions that are sensitive to primary care [33]. The fol-
lowing health problems were investigated: leukopenia, 
leukocytosis, diabetes mellitus, hypercholesterolemia, 
kidney failure, anemia, thrombocytopenia, and arte-
rial hypertension. Charts S1 and S2 in the Additional 
File 1 list the corresponding biomarkers, their ranges for 
abnormal results and the proportion of tests according to 
the defined ranges.
As the laboratory results were made available sepa-
rately from the PNS 2013 survey, it was necessary to 
adopt a procedure for merging both datasets to associ-
ate each biomarker level with the corresponding inter-
viewed individual. To this end, an identification key was 
built based on the following information presented in 
both datasets: weight, height, sex, age, ethnicity, health 
self-evaluation, and level of education. The identification 
keys were complemented with specific questions (doc-
tor appointments, nourishment, and health insurance) 
to maximize the key variability and the percentage of 
matches. This key proved to have a success rate of 99.8%: 
from the 8952 individuals tested, only 17 did not match.
1 For details on the sample design of the PNS 2013, see [17].
2 The second edition of the PNS was carried out in 2019, but no laboratory 
tests were conducted in this edition.
3 All data used in this study were made publicly available on the internet 
[20–22] by the institutions responsible for collecting the data, so no ethi-
cal approval was required. The Brazilian legislation (Resolution 510, of April 
7, 2016, from the National Health Council/Health Ministry) establishes that 
studies that use information with public access will not be registered or 
evaluated by the Research Ethics Committee. This study fits into that cat-
egory.
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As the PNS allowed for the identification of the state 
and, if applicable, the metropolitan area that each sur-
veyed household was in, it was possible to associate 
each laboratory result to the regional supply of the ESF 
teams.4 This represented an opportunity to assess poten-
tial positive externalities of the program. The hypothesis 
to be tested was whether a higher supply of health pri-
mary care services, measured by the number of the ESF 
teams by 10,000 inhabitants near the household, implied 
a more effective result because nonregistered individuals 
could benefit indirectly from spillover effects produced 
by health interventions [34, 35]. Therefore, in addition to 
assessing the direct channels by which the ESF program 
affects individual health, this study aimed to contribute 
by testing whether there was an indirect effect coming 
from the density of the ESF teams within the state or the 
metropolitan area in which the individual lived.
To do so, the measure of coverage was disaggregated 
into two direct dimensions and one indirect dimension, 
as follows:
ESF registration: This is a binary variable (dummy) that 
equals one if the household was registered in the ESF pro-
gram and zero otherwise, according to the individual’s 
answer in the PNS 2013. This variable is a measure of cov-
erage and captures the direct effect of being assisted by an 
ESF team.
ESF visits: This is the number of annual visits received 
by the household. The survey asked how often an ESF 
agent visited the household in the 12 months prior to the 
survey, and the number of visits was calculated according 
to the option chosen by the respondent. This variable was 
included to evaluate whether the intensity of primary care 
coverage had any relationship with the laboratory results.
ESF program supply: This is the number of ESF teams 
by 10,000 inhabitants deployed to the metropolitan area 
or to the state in which the respondent dwelt in 2013 
(source: Datasus [21]).
The answers from the PNS allowed us to include three 
main sets of control variables5:
Individual characteristics: sex, age, ethnicity, marital 
status, highest educational level (completed high school 
or completed college), individual health insurance, 
smoking status and practice of physical activity at least 
once a week.
Individual health conditions: obesity (individuals with 
a Body Mass Index > 30 kg/m2); waist circumference; a 
previous diagnosis of the following conditions: chronic 
disease, kidney failure, heart condition, diabetes, can-
cer and/or high blood pressure; and if the individual was 
hospitalized in the 12 months prior to the survey.
Household characteristics: household income per cap-
ita, participation in the federal cash transfer program 
(Bolsa Familia), and the presence of piped water, elec-
tric power, sanitation, and/or garbage collection. These 
covariates aimed to control for socioeconomic character-
istics that affect health. The descriptive statistics of both 
coverage and control variables can be found in Tables S1 
and S2 in the Additional File 1.
Additionally, the number of hospital beds per capita 
was included to control for the regional/local supply of 
health facilities (Source: Datasus [21]).
The final number of individuals tested was below the 
actual drawn number due to logistic difficulties, which 
required a poststratification procedure. Sampling weights 
were calculated for use of the laboratory exam dataset, 
given the poststratification procedures by sex, age, eth-
nicity, and educational level according to large regions, 
from the total sample of the PNS [18]. Fiocruz released 
the weights of the laboratory exams, which were used to 
weigh the standard deviations of the estimates [18].
The relationship between ESF program coverage and 
individual health was estimated through a probability 
model, in which the dependent variable presented the 
likelihood of an abnormal biomarker level. The probit 
model can be generically expressed as (1):
where y is the binary variable equal to one if the result of 
the individual laboratory test is out of the reference range 
for the corresponding biomarker (Table S1 – Additional 
File 1) and zero otherwise, and X is the vector containing 
the set of controls. Φ(.) is the cumulative of the standard 
normal distribution.
Results
Tables 1, 2, 3, 4 present the results for the likelihood of 
abnormalities in biomarkers, expressed as probit mar-
ginal effects.6 With the purpose of assessing both direct 
and indirect effects, the estimates were grouped by the 
















4 While the PNS does not identify the surveyed municipalities, its design 
allows the identification of whether a household is located in a metropolitan 
area. As created by the law, metropolitan areas are clusters of urban cities that 
coordinate joint actions of development and set up unified policies to address 
common problems. According to the last Brazilian National Census (2010), 
approximately 40% of the Brazilian population dwelt in 21 metropolitan areas 
around the state capitals. Among the 8900 individual lab tests, there was a 
subsample of 3879 collected across 21 identifiable metropolitan areas.
5 Nonquantitative characteristics were measured through binary variables 
that assumed value one if the individual fulfilled the characteristic and zero 
otherwise.
6 The marginal effect means the change in the likelihood of a disease/comor-
bidity given a small change in the explicative variable. For binary explicative 
variables, the marginal effect must be interpreted as the change in the likeli-
hood of disease if the explicative variable changes from 0 to 1.
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into account and considered only household coverage 
(ESF program registration and ESF visits); Specification II 
considered only individuals that were tested in metropol-
itan areas with household coverage and metropolitan ESF 
supply, as defined in the previous section; Specification 
III took into account all individuals that were tested with 
household coverage and the corresponding state ESF sup-
ply; and finally, Specification IV considered the full sam-
ple and household coverage (as Spec. I) but replaced the 
regional health facilities with binary variables that identi-
fied the state or, if applicable, the metropolitan area the 
respondent dwelt in, with the purpose of capturing the 
specific regional effects.
Table 1 exhibits the results for Specification I. Except for 
diabetes mellitus and high cholesterol, being registered in 
the ESF program was associated with a lower likelihood of 
abnormal ranges of biomarkers linked to all comorbidities. 
Kidney failure had the smallest marginal effect, i.e., the like-
lihood of observing an abnormal biomarker for this health 
condition was approximately 1.19 p.p. lower in registered 
individuals than in nonregistered individuals, whereas the 
likelihood reached 2.16 p.p. for anemia. Although being 
registered in the ESF program was negatively associated 
with the likelihood of thrombocytopenia (marginal effect of 
− 1.37 p.p.), the number of visits, on the other hand, was 
positively associated with the likelihood of this comorbidity.
Table 1 Results considering only household coverage (Spec. I)
Weighted standard errors are in parentheses; *** p < 0.01, ** p < 0.05, * p < 0.1. All results were controlled for the individual characteristics (sex, age, ethnicity, marital 
status, educational level), individual health conditions (obesity, waist measure, previous diagnosis of chronic diseases, kidney condition, heart condition, diabetes, 
cancer, high blood pressure, hospitalized in the previous 12 months), household characteristics (presence of piped water, electric power, sanitation, garbage 
collection, household income per capita), whether the individual was covered by health insurance or not, if they are were Bolsa Familia recipient or not, if they 
participated in sports or not, and if they were a smoker or not.








−0.0192** − 0.0186** − 0.00847 0.00287 − 0.0119** − 0.0137** −0.0216** − 0.0162**
(0.00979) (0.0094) (0.00707) (0.00597) (0.00465) (0.0056) (0.00982) (0.00797)
ESF visits 0.00180* 0.000266 0.000454 −0.000382 − 0.000247 0.00141*** − 0.000893 − 0.00043
(0.00095) (0.0009) (0.00068) (0.00058) (0.000483) (0.0005) (0.000975) (0.000785)
Health facilities −0.00404*** −0.0143*** − 0.0079*** −0.000729 − 0.00106* −0.00103 0.000204 0.0026***
(0.0012) (0.00116) (0.00088) (0.00076) (0.000574) (0.00066) (0.00123) (0.001)
Observations 8831 8831 8831 8831 8831 8831 8831 8831
Table 2 Results considering household coverage and metropolitan ESF supply (Spec. II)
Weighted standard errors are in parentheses; *** p < 0.01, ** p < 0.05, * p < 0.1. All results were controlled for the individual characteristics (sex, age, ethnicity, 
marital status, educational level), individual health conditions (obesity, waist measure, previous diagnosis of chronic diseases, kidney condition, heart condition, 
diabetes, cancer, high blood pressure, hospitalized in the previous 12 months), household characteristics (presence of piped water, electric power, sanitation, 
garbage collection, household income per capita), whether the individual was covered by health insurance or not, if they were a Bolsa Familia recipient or not, if they 
participated in sports or not, and if they were a smoker or not. The metropolitan ESF supply was measured as the number of local ESF teams by 10,000 inhabitants at 
the metropolitan level.








−0.0203* − 0.0209* − 0.0103 − 0.00515 −0.00877 − 0.0107 −0.00766 − 0.0129
(0.0118) (0.0119) (0.00968) (0.0087) (0.00660) (0.007) (0.0137) (0.0107)
ESF visits −0.00088 0.000526 −7.67E-05 −0.000101 − 0.000493 − 0.00017 0.00173 0.000883
(0.00137) (0.0013) (0.00107) (0.00098) (0.000819) (0.0007) (0.00155) (0.00117)
Metropoli-
tan ESF supply
0.00889 −0.0160 − 0.00341 − 0.00447 − 0.0168*** 0.00706 − 0.0607*** −0.0302***
(0.0102) (0.0108) (0.00872) (0.00779) (0.00640) (0.006) (0.0122) (0.0099)
Health facili-
ties
−0.00069 −0.0059*** −0.0049*** − 0.00043 0.000259 − 0.00003 0.00592*** − 0.000553
(0.0012) (0.00124) (0.00104) (0.00095) (0.000716) (0.00071) (0.00145) (0.00117)
Observations 3840 3840 3840 3815 3829 3840 3840 3840
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The spillover effect at the metropolitan level (Table 2) 
was statistically significant for kidney failure, anemia and 
arterial hypertension. On average, the increase of one 
ESF team per 10 thousand inhabitants in metropolitan 
areas decreased the likelihood of kidney failure by 1.68 
p.p., the likelihood of anemia by 6.07 p.p. and the likeli-
hood of arterial hypertension by 3.02 p.p. Under this 
specification, the household coverage effect disappeared 
for all conditions, except leukopenia and leukocytosis at a 
10% significance level.
Except for diabetes mellitus and abnormal cholesterol 
levels, registration in the ESF program remained signifi-
cant for all health conditions when the spillover effect at 
the state level was included (Table  3), with magnitudes 
similar to Specification I (Table  1). Additionally, the 
positive association between visits and the likelihood of 
thrombocytopenia remained. However, the ESF supply 
at the state level proved to be significant only for arterial 
hypertension (marginal effect of − 1.61 p.p.) and for dia-
betes mellitus (− 0.7 p.p at a 10% significance level). The 
association between ESF supply at the state level and leu-
kopenia was positive and significant at the 1% level.
When the health facilities were replaced with metro-
politan and state-specific effects (Table  4), the negative 
association between household coverage remained sta-
tistically significant for kidney failure, thrombocytopenia 
and arterial hypertension, as well as the positive asso-
ciation between thrombocytopenia and the number of 
visits.
Finally, diabetes mellitus was the only comorbid-
ity whose decrease in likelihood was robustly linked to 
health facilities because the effect of hospital bed density 
was negative and statistically significant at both the state 
and metropolitan levels. The other health conditions 
Table 3 Results considering household coverage and state ESF supply (Spec. III)
Weighted standard errors are in parentheses; *** p < 0.01, ** p < 0.05, * p < 0.1. All results were controlled for the individual characteristics (sex, age, ethnicity, 
marital status, educational level), individual health conditions (obesity, waist measure, previous diagnosis of chronic diseases, kidney condition, heart condition, 
diabetes, cancer, high blood pressure, hospitalized in the previous 12 months), household characteristics (presence of piped water, electric power, sanitation, 
garbage collection, household income per capita), whether the individual was covered by health insurance or not, if they were a Bolsa Familia recipient or not, if they 
participated in sports or not, and if they were a smoker or not. The state ESF supply was measured as the number of ESF teams by 10,000 inhabitants at the state level.








−0.0209** − 0.0187** − 0.0078 0.00236 − 0.0118** − 0.0137** − 0.0218** −0.0148*
(0.0098) (0.0094) (0.00708) (0.00599) (0.00465) (0.0056) (0.00983) (0.00797)
ESF visits 0.00151 0.000251 0.000139 −0.000447 −0.000222 0.00141*** −0.00094 − 0.000211
(0.00095) (0.0009) (0.00068) (0.00058) (0.000486) (0.0005) (0.000979) (0.00078)
State ESF sup-
ply
0.0226*** 0.00114 −0.00771* 0.00484 −0.00143 −7.07E-05 0.00337 −0.0161***
(0.0062) (0.0059) (0.00458) (0.0039) (0.00308) (0.0034) (0.00636) (0.00528)
Health facili-
ties
−0.00329*** − 0.0142*** − 0.0081*** −0.000552 − 0.00111* −0.00103 0.000328 0.00197*
(0.0012) (0.00117) (0.00089) (0.00077) (0.000584) (0.00067) (0.00125) (0.00102)
Observations 8831 8831 8831 8831 8831 8831 8831 8831
Table 4 Results considering household coverage with state and metropolitan fixed effects (Spec. IV)
Weighted standard errors are in parentheses; *** p < 0.01, ** p < 0.05, * p < 0.1. All results were controlled for the individual characteristics (sex, age, ethnicity, marital 
status, educational level), individual health conditions (obesity, waist measure, previous diagnosis of chronic diseases, kidney condition, heart condition, diabetes, 
cancer, high blood pressure, hospitalized in the previous 12 months), household characteristics (presence of piped water, electric power, sanitation, garbage 
collection, household income per capita), whether the individual was covered by health insurance or not, if they were a Bolsa Familia recipient or not, if they practiced 
sports or not, and if they were a smoker or not. Health facilities were replaced with state and metropolitan binary variables.








−0.0141 − 0.00394 − 0.00248 0.00297 − 0.0101** − 0.0141** − 0.0135 − 0.0174**
(0.00988) (0.0092) (0.00704) (0.00607) (0.00480) (0.0057) (0.0099) (0.0081)
ESF visits 0.000666 −5.9E-05 0.000462 −0.00033 −0.000289 0.00126** −0.000239 −0.000598
(0.00097) (0.0009) (0.00069) (0.0006) (0.000513) (0.0005) (0.000994) (0.000808)
Observations 8831 8831 8831 8831 8831 8831 8831 8831
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did not present a clear relationship with this variable, 
whereas anemia (in metropolitan areas) and arterial 
hypertension both presented a positive association.
Discussion
Leukopenia and leukocytosis can arise as a result of 
several diseases, and it is difficult to assess the channel 
through which the ESF program acts on the correspond-
ing biomarkers. The results suggest that household reg-
istration is negatively correlated with the likelihood of 
observing such conditions. Because hospitalizations aris-
ing from acute infectious diseases, such as tuberculosis 
and syphilis, are avoidable through primary care services 
[33], one possible explanation for the obtained results is 
that preventive actions in long-term primary care con-
tribute to a decrease in the incidence of infections and to 
the maintenance of immunity in general.
There is well-documented evidence of altered cho-
lesterol levels in the Brazilian adult population, mainly 
among women, elderly people and less educated people 
[36]. Additionally, the prevalence of diabetes among the 
Brazilian adult population is approximately 10% [37]. 
The results for diabetes mellitus and cholesterol revealed 
no direct effect of the ESF program on the likelihood of 
abnormal levels of their corresponding biomarkers. On 
the other hand, the presence of health facilities seemed 
to be more important than primary care services for 
diabetes, as the effect of hospital bed density was nega-
tive and significant for all specifications regarding this 
disease. The indirect effect appeared only for diabetes at 
the state level, with a 10% significance level. These results 
seem disappointing, as one would expect that the ESF 
directly impacts diabetes and cholesterol though edu-
cative actions, since these two conditions have an asso-
ciation with poor eating habits. There is accumulated 
evidence [11] that the intensity of ESF services can reduce 
premature mortality from complications of hypertension, 
heart failure, cerebrovascular diseases, and diabetes. This 
combination of results seems to indicate that the develop-
ment of diabetes and hypercholesterolemia is multifacto-
rial, mixing environmental and genetic causes that are not 
addressed by the ESF program. Nevertheless, although 
the ESF program is unable to mitigate both conditions, 
the program is effective in reducing some of their most 
serious consequences in the long run, such as mortality.
Kidney failure and anemia are both more prevalent 
among elderly people and the low-income population in 
Brazil [19, 38]. The results suggest a negative association 
between the likelihood of such comorbidities and ESF 
program coverage, which signals that the program has 
been successful in addressing these comorbidity-vulner-
able populations.
The ESF program dynamics in the metropolitan regions 
seemed to be quite different than the average because 
individual coverage was not significant for all comorbidi-
ties within such regional constituencies, except leukope-
nia and leukocytosis at a 10% significance level. On the 
other hand, the spillover effects seemed to be negatively 
associated with kidney failure, anemia and high blood 
pressure in the metropolitan areas. The reasons for these 
results deserve deeper investigation. It is possible that 
the dynamics of the ESF in great urban clusters are dif-
ferent from those in smaller cities and include integrated 
actions with other agents that are not directly linked to 
primary care coverage.
The number of annual visits was positively associated 
with thrombocytopenia, which was against the expected 
effect. Although a low blood platelet count is not pre-
ventable in most cases, it can denote/signal several health 
problems [39]—a deficiency of vitamin B12, liver diseases 
(cirrhosis), spleen problems, alcohol abuse, hepatitis C, 
some types of leukemia, or changes in bone marrow. It 
is possible that ESF teams more often visit households 
whose residents suffer from chronic diseases associated 
with this biomarker, which would explain the obtained 
effects, but this hypothesis deserves more investigation.
The spillover effect was strong for arterial hyperten-
sion, both at the metropolitan and state levels. Except in 
metropolitan areas, being registered in the ESF program 
was also important for avoiding hypertension, reducing 
the likelihood of abnormal biomarkers. This result is in 
accordance with recent evidence that the ESF program 
reduces mortality from complications of hypertension, 
including cerebrovascular diseases [8, 11].
It is important to emphasize that, given the empirical 
strategy adopted in this study and the limitation of the 
datasets, a statistically significant result does not neces-
sarily mean causality because the exposure and the out-
come measures were taken at the same time (2013). It is 
wiser to interpret the results as statistically significant 
contemporary relationships. Nonetheless, the findings 
reveal important connections to guide public policies on 
primary health care.
Unfortunately, the sample design of the PNS 2013 
did not allow us to identify all the municipalities where 
the data were collected, but only the federation unit 
and the metropolitan region, if applicable. For a more 
refined study of the relationship between the density of 
ESF teams and the effects on individual health, it would 
be necessary to identify the location of each household; 
this would be an interesting next step for this research. 
Despite this limitation, this paper contributes to the field 
as a first investigation and could shed light on important 
policy priorities for primary health care in Brazil.
Page 7 of 8Postali et al. BMC Health Services Research         (2021) 21:1300  
Conclusions
Rather than having a unique objective, the Family Health 
Strategy has a set of multiple actions, as the most impor-
tant primary care program in Brazil, from preventing 
infant mortality to referring patients for more complex 
procedures in outpatient clinics and hospitals. In this 
sense, it is not easy to draw objective policy conclusions 
from the results mentioned above. They reveal a complex 
combination of direct and indirect effects, with different 
linkages according to the type of coverage, the intensity 
of care and the dwelling region. Nonetheless, the results 
here allow us to state that increasing primary care cover-
age is a promising strategy to address important comor-
bidities in low- to middle-income countries. Moreover, 
the presence of indirect effects (spillover) suggests that 
health authorities should treat metropolitan areas in a 
different fashion, developing specific and coordinated 
actions among the municipalities that belong to them.
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